🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-08-08
Trial ID
NCT05941585
Treatments Being Tested
Central nervous system (CNS) relapses of aggressive lymphomas are a rare bu...
Status
Unknown
Location
Charité Universitätsmedizin
Start Date
2007-10
Trial ID
NCT01148173
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02532192
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
The purpose of this trial is to test the safety and tolerance of the combin...
Status
Terminated
Location
Neurologische Universitaetsklinik Bonn
Start Date
2012-03
Trial ID
NCT01563614
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
This is a single-arm, open-label clinical trial evaluating the safety and p...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-08
Trial ID
NCT07490288
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
Children's Hospital Los Angeles
Start Date
1997-02
Trial ID
NCT00003073
Treatments Being Tested
To confirm the efficacy of CPX-351 compared to 7+3 as first line therapy in...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-12-13
Trial ID
NCT01696084
Treatments Being Tested